Medline Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDLN research report →
Companywww.medline.com
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.
- CEO
- James Boyle
- IPO
- 2025
- Employees
- 43,000
- HQ
- Northfield, IL, US
Price Chart
Valuation
- Market Cap
- $30.65B
- P/E
- 30.80
- P/S
- 1.05
- P/B
- 2.63
- EV/EBITDA
- 13.92
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 24.04%
- Op Margin
- 7.04%
- Net Margin
- 3.31%
- ROE
- 6.87%
- ROIC
- 5.01%
Growth & Income
- Revenue
- $28.43B · 11.47%
- Net Income
- $1.16B · -3.42%
- EPS
- $1.43 · -5.92%
- Op Income
- $2.21B
- FCF YoY
- 24.13%
Performance & Tape
- 52W High
- $50.88
- 52W Low
- $34.89
- 50D MA
- $43.21
- 200D MA
- $43.79
- Beta
- 0.18
- Avg Volume
- 7.08M
Get TickerSpark's AI analysis on MDLN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 10, 26 | Carlyle Group Inc. | sell | 26,105,840 |
| Mar 10, 26 | Carlyle Group Inc. | other | 2,113,483 |
| Mar 10, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 16,479,083 |
| Mar 10, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 1,886,636 |
| Mar 10, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 366,337 |
| Mar 10, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 8,241,723 |
| Mar 10, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 1,245,544 |
| Mar 5, 26 | Carlyle Group Inc. | other | 1,212,767 |
| Mar 4, 26 | Carlyle Group Inc. | other | 8,085,116 |
| Mar 4, 26 | Carlyle Group Inc. | other | 8,085,116 |
Our MDLN Coverage
View all →
Medline (MDLN): Scale and Retention Support a Buy
Medline is growing at scale with strong customer retention and a deep med-surg distribution network, but margin pressure and a rich valuation keep the stock from looking cheap.
Medline Inc. (MDLN) drops 7.7% after Q1 margin hit
Medline Inc. (MDLN) drops sharply after its Q1 2026 earnings report showed strong revenue growth but weaker profitability. Investors are reacting to margin compression from tariffs, higher operating costs, and IPO-related expenses, even as full-year sales guidance improved.
Want a deeper read on MDLN?
Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.